Eric H. Y. Lau

37.8k total citations · 8 hit papers
235 papers, 7.9k citations indexed

About

Eric H. Y. Lau is a scholar working on Infectious Diseases, Modeling and Simulation and Epidemiology. According to data from OpenAlex, Eric H. Y. Lau has authored 235 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 119 papers in Infectious Diseases, 100 papers in Modeling and Simulation and 98 papers in Epidemiology. Recurrent topics in Eric H. Y. Lau's work include COVID-19 epidemiological studies (100 papers), Influenza Virus Research Studies (75 papers) and SARS-CoV-2 and COVID-19 Research (72 papers). Eric H. Y. Lau is often cited by papers focused on COVID-19 epidemiological studies (100 papers), Influenza Virus Research Studies (75 papers) and SARS-CoV-2 and COVID-19 Research (72 papers). Eric H. Y. Lau collaborates with scholars based in Hong Kong, China and United Kingdom. Eric H. Y. Lau's co-authors include Benjamin J. Cowling, GM Leung, Peng Wu, Malik Peiris, Jessica Y. Wong, Joseph T. Wu, Tim K. Tsang, Kathy Leung, Carlos King Ho Wong and Sheikh Taslim Ali and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Eric H. Y. Lau

222 papers receiving 7.7k citations

Hit Papers

Clustering and supersprea... 2020 2026 2022 2024 2020 2022 2022 2021 2022 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong
    2020 409 citations Dillon C. Adam, Peng Wu et al. Nature Medicine profile →
  2. Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study
    2022 229 citations Yun Lin, Jessica Y. Wong et al. The Lancet Infectious Diseases profile →
  3. Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination
    2022 211 citations Chris Ka Pun Mok, Eric H. Y. Lau et al. Nature Medicine profile →
  4. Neutralizing antibody titres in SARS-CoV-2 infections
    2021 209 citations Eric H. Y. Lau, Ranawaka A. P. M. Perera et al. Nature Communications profile →
  5. Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study
    2022 187 citations Carlos King Ho Wong, Ivan Chi Ho Au et al. The Lancet profile →
  6. Real-world effectiveness of early molnupiravir or nirmatrelvir–ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong's omicron BA.2 wave: a retrospective cohort study
    2022 155 citations Carlos King Ho Wong, Ivan Chi Ho Au et al. The Lancet Infectious Diseases profile →
  7. Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population
    2023 116 citations Kathy Leung, Eric H. Y. Lau et al. Nature Medicine profile →
  8. Estimating the transmission dynamics of SARS-CoV-2 Omicron BF.7 in Beijing after adjustment of the zero-COVID policy in November–December 2022
    2023 107 citations Kathy Leung, Eric H. Y. Lau et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric H. Y. Lau Hong Kong 49 4.2k 2.8k 2.6k 793 642 235 7.9k
Peng Wu Hong Kong 41 2.7k 0.6× 2.2k 0.8× 2.3k 0.9× 760 1.0× 536 0.8× 200 6.9k
Joseph T. Wu Hong Kong 44 4.9k 1.2× 3.0k 1.1× 4.9k 1.9× 1.0k 1.3× 799 1.2× 153 11.1k
Steven Riley United Kingdom 55 4.5k 1.1× 5.1k 1.8× 6.2k 2.4× 1.4k 1.7× 535 0.8× 187 11.9k
David N. Fisman Canada 50 3.7k 0.9× 3.4k 1.2× 3.0k 1.2× 244 0.3× 702 1.1× 241 11.8k
Lyn Finelli United States 56 3.3k 0.8× 10.0k 3.5× 2.5k 0.9× 449 0.6× 1.2k 1.9× 179 14.0k
Carrie Reed United States 36 1.9k 0.4× 4.1k 1.5× 2.1k 0.8× 312 0.4× 705 1.1× 145 6.4k
Pierre‐Yves Boëlle France 56 3.1k 0.7× 4.4k 1.6× 4.1k 1.6× 367 0.5× 579 0.9× 302 12.7k
Niel Hens Belgium 50 2.8k 0.7× 4.6k 1.6× 4.0k 1.5× 391 0.5× 1.4k 2.2× 382 11.0k
Jonathan S. Nguyen‐Van‐Tam United Kingdom 44 2.8k 0.7× 3.5k 1.3× 858 0.3× 189 0.2× 596 0.9× 168 7.5k
Maria D. Van Kerkhove United Kingdom 37 3.4k 0.8× 1.7k 0.6× 1.6k 0.6× 441 0.6× 234 0.4× 86 5.5k

Countries citing papers authored by Eric H. Y. Lau

Since Specialization
Citations

This map shows the geographic impact of Eric H. Y. Lau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric H. Y. Lau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric H. Y. Lau more than expected).

Fields of papers citing papers by Eric H. Y. Lau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric H. Y. Lau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric H. Y. Lau. The network helps show where Eric H. Y. Lau may publish in the future.

Co-authorship network of co-authors of Eric H. Y. Lau

This figure shows the co-authorship network connecting the top 25 collaborators of Eric H. Y. Lau. A scholar is included among the top collaborators of Eric H. Y. Lau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric H. Y. Lau. Eric H. Y. Lau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lau, Eric H. Y., et al.. (2025). Improving influenza forecast in the tropics and subtropics: a case study of Hong Kong. Journal of The Royal Society Interface. 22(222). 20240649–20240649.
2.
Lam, Kwok Fai, et al.. (2025). Estimation of trajectory of COVID-19 vaccines effectiveness against infection. Vaccine. 55. 127067–127067.
3.
Lam, Kwok Fai, et al.. (2025). Joint analysis of time-varying effect of vaccine and antiviral drug for preventing severe complications and mortality. Scientific Reports. 15(1). 5640–5640. 3 indexed citations
4.
Lau, Yiu Chung, Sukhyun Ryu, Zhanwei Du, et al.. (2024). Impact of COVID-19 control measures on respiratory syncytial virus and hand-foot-and-mouth disease transmission in Hong Kong and South Korea. Epidemics. 49. 100797–100797. 1 indexed citations
5.
6.
Du, Zhanwei, Lin Wang, Yuan Bai, et al.. (2024). A retrospective cohort study of Paxlovid efficacy depending on treatment time in hospitalized COVID-19 patients. eLife. 13. 5 indexed citations
7.
Lau, Eric H. Y., et al.. (2024). Joint analysis of vaccination effectiveness and antiviral drug effectiveness for COVID-19: a causal inference approach. International Journal of Infectious Diseases. 143. 107012–107012. 5 indexed citations
8.
9.
Wong, Jessica Y., Justin Cheung, Yun Lin, et al.. (2023). Intrinsic and Effective Severity of Coronavirus Disease 2019 Cases Infected With the Ancestral Strain and Omicron BA.2 Variant in Hong Kong. The Journal of Infectious Diseases. 228(9). 1231–1239. 16 indexed citations
10.
Dabak, Saudamini Vishwanath, Minah Park, Alex R. Cook, et al.. (2023). Effectiveness of chatbots on COVID vaccine confidence and acceptance in Thailand, Hong Kong, and Singapore. npj Digital Medicine. 6(1). 96–96. 16 indexed citations
11.
Leung, Kathy, Eric H. Y. Lau, Carlos King Ho Wong, GM Leung, & Joseph T. Wu. (2023). Estimating the transmission dynamics of SARS-CoV-2 Omicron BF.7 in Beijing after adjustment of the zero-COVID policy in November–December 2022. Nature Medicine. 29(3). 579–582. 107 indexed citations breakdown →
12.
Du, Zhanwei, Lin Wang, Yuan Bai, et al.. (2023). Cost effectiveness of fractional doses of COVID-19 vaccine boosters in India. Med. 4(3). 182–190.e3. 5 indexed citations
13.
Wong, Carlos King Ho, Ivan Chi Ho Au, Kristy T. K. Lau, et al.. (2022). Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study. The Lancet. 400(10359). 1213–1222. 187 indexed citations breakdown →
14.
Lin, Yun, Bingyi Yang, Sarah Cobey, et al.. (2022). Incorporating temporal distribution of population-level viral load enables real-time estimation of COVID-19 transmission. Nature Communications. 13(1). 1155–1155. 18 indexed citations
15.
Kang, Min, Hualei Xin, Jun Yuan, et al.. (2022). Transmission dynamics and epidemiological characteristics of SARS-CoV-2 Delta variant infections in Guangdong, China, May to June 2021. Eurosurveillance. 27(10). 66 indexed citations
16.
Tsang, Tim K., Peng Wu, Eric H. Y. Lau, & Benjamin J. Cowling. (2021). Accounting for Imported Cases in Estimating the Time-Varying Reproductive Number of Coronavirus Disease 2019 in Hong Kong. The Journal of Infectious Diseases. 224(5). 783–787. 16 indexed citations
17.
Mok, Chris Ka Pun, Airu Zhu, Jingxian Zhao, et al.. (2020). T-cell responses to MERS coronavirus infection in people with occupational exposure to dromedary camels in Nigeria: an observational cohort study. The Lancet Infectious Diseases. 21(3). 385–395. 42 indexed citations
18.
Xu, Yi, David J. Baylink, Chien-Shing Chen, et al.. (2020). The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19. Journal of Translational Medicine. 18(1). 322–322. 126 indexed citations
19.
Ali, Sheikh Taslim, Lin Wang, Eric H. Y. Lau, et al.. (2020). Serial interval of SARS-CoV-2 was shortened over time by nonpharmaceutical interventions. Science. 369(6507). 1106–1109. 217 indexed citations
20.
Lau, Eric H. Y., C. Cheng, Dkm Ip, & Benjamin J. Cowling. (2012). Situational Awareness of Influenza Activity Based on Multiple Streams of Surveillance Data Using Multivariate Dynamic Linear Model. PLoS ONE. 7(5). e38346–e38346. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peng Wu Breakdown of academic impact, for papers by Joseph T. Wu Breakdown of academic impact, for papers by Steven Riley Breakdown of academic impact, for papers by David N. Fisman Breakdown of academic impact, for papers by Lyn Finelli Breakdown of academic impact, for papers by Carrie Reed Breakdown of academic impact, for papers by Pierre‐Yves Boëlle Breakdown of academic impact, for papers by Niel Hens Breakdown of academic impact, for papers by Jonathan S. Nguyen‐Van‐Tam Breakdown of academic impact, for papers by Maria D. Van Kerkhove
Rankless by CCL
2026